Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus

Authors:

Abstract
Nonalcoholic steatohepatitis (NASH) is a common chronic liver condition affecting obese patients with prediabetes or type 2 diabetes mellitus (T2DM). Pioglitazone seems to target metabolic defects,... Background: The metabolic defects of nonalcoholic steatohepatitis (NASH) and prediabetes or type 2 diabetes mellitus (T2DM) seem to be specifically targeted by pioglitazone. However, information ab...
Funding Information
  • U.S. Department of Veterans Affairs (1 I01 CX000167-01)
  • American Diabetes Association
  • Burroughs Wellcome Fund

This publication has 61 references indexed in Scilit: